HEALTHXBSEHealth X Platform LtdHighNeutral
Announced Sat, 30 May · 18:44 IST

Intimation of Re-appointment of Internal Auditors of the Company

Revenue Growth 20pctPat NegativeGoing ConcernResults View source PDF

HEALTHX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹305.55
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-1.6+0.8-0.2-2.9-6.4+3.3+3.1
Up moveDown movePending
AI summary

Health X Platform Limited reported FY2026 audited results showing mixed performance. On a consolidated basis, total revenue grew 18.7% to Rs 1,31,927 lakhs from Rs 1,11,095 lakhs, driven mainly by the Healthcare Network segment (Rs 1,28,316 lakhs). The consolidated net loss improved dramatically to Rs 145 lakhs from Rs 13,354 lakhs in FY2025. However, standalone results remain weak with revenue declining to Rs 38 lakhs from Rs 40 lakhs and standalone net loss widening to Rs 95 lakhs from Rs 71 lakhs. The company changed its name from Sastasundar Ventures Limited to Health X Platform Limited during the year. Statutory auditors JKVS & Co issued unmodified opinions on both standalone and consolidated financials. An Emphasis of Matter was raised regarding Genu Path Labs Limited (step-down subsidiary) due to going concern uncertainty. M/s Priya Gupta & Co was re-appointed as internal auditor for FY2026-27.

Likely market impact

The consolidated results show meaningful improvement in reducing losses, though the company remains in loss territory. The standalone entity continues to burn cash with widening losses. The going concern emphasis on a subsidiary raises risk flags for investors. The internal auditor re-appointment is routine with no material implications.